Efficacy of Tamoxifen Versus Toremifene in CYP2D6 IM/PM of Premenopausal Patients With ER-positive Early Breast Cancer

PHASE3RecruitingINTERVENTIONAL
Enrollment

844

Participants

Timeline

Start Date

November 30, 2017

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Breast Cancer Female
Interventions
DRUG

Tamoxifen

Patients will be given 10mg Tamoxifen twice a day.

DRUG

Toremifene

Patients will be given 60mg Toremifene once a day.

Trial Locations (21)

Unknown

RECRUITING

Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing

RECRUITING

First Affiliated Hospital of Chongqing Medical University, Chongqing

RECRUITING

Southwest Hospital, China, Chongqing

RECRUITING

Union hospital of Fujian Medical University, Fuzhou

RECRUITING

Guangdong Provincial People's Hospital, Guangzhou

RECRUITING

Sun Yat-sen Memorial Hospital, Guangzhou

RECRUITING

Hainan People's Hospital, Haikou

RECRUITING

Hebei Tumor Hospital, Shijiazhuang

RECRUITING

Harbin Medical University Cancer Hospital, Harbin

RECRUITING

Henan Cancer Hospital, Zhengzhou

RECRUITING

Wuhan Tongji Hospital, Wuhan

RECRUITING

Hunan Cancer Hospital, Changsha

RECRUITING

Jiangsu Provincial People's Hospital, Nanjing

RECRUITING

The Third Affiliated Hospital of Nanchang University, Nanchang

RECRUITING

First Hospital of Jilin University, Changchun

RECRUITING

First Hospital of China Medical University, Shenyang

RECRUITING

First Affiliated Hospital of Qingdao University, Qingdao

RECRUITING

Fudan University Shanghai Cancer Center, Shanghai

RECRUITING

Tianjin Medical University Cancer Institute and Hospital, Tianjin

RECRUITING

The Third Affiliated Hospital of Kunming Medical College, Kunming

RECRUITING

Zhejiang Cancer Hospital, Hangzhou

All Listed Sponsors
collaborator

Fudan University

OTHER

collaborator

Henan Cancer Hospital

OTHER_GOV

collaborator

The First Hospital of Jilin University

OTHER

collaborator

Southwest Hospital, China

OTHER

collaborator

First Hospital of China Medical University

OTHER

collaborator

Guangdong Provincial People's Hospital

OTHER

collaborator

Harbin Medical University

OTHER

collaborator

First Affiliated Hospital of Chongqing Medical University

OTHER

collaborator

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

OTHER

collaborator

Jiangsu Provincial People's Hospital

OTHER

collaborator

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

OTHER

collaborator

Zhejiang Cancer Hospital

OTHER

collaborator

Tianjin Medical University Cancer Institute and Hospital

OTHER

collaborator

Union hospital of Fujian Medical University

OTHER

collaborator

Hebei Tumor Hospital

OTHER

collaborator

Hunan Cancer Hospital

OTHER

collaborator

Affiliated Hospital of Qinghai University

OTHER

collaborator

Wuhan TongJi Hospital

OTHER

collaborator

Hainan People's Hospital

OTHER

collaborator

The Third Affiliated Hospital of Kunming Medical College.

OTHER

collaborator

The Third Affiliated Hospital of Nanchang University

OTHER

lead

Chinese Anti-Cancer Association

OTHER